Praxis Precision Medicines (PRAX) Misses Q1 EPS by 284c
Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($2.84). Revenue for the quarter came in at $430 thousand.
For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.
